Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3654920

Tepoxalin, a novel immunomodulatory compound, synergizes with CSA in suppression of graft-versus-host reaction and allogeneic skin graft rejection

Author
WAI-PING FUNG-LEUNG; POPE, B. L; CHOURMOUZIS, E; PANAKOS, J. A; LAU, C. Y
R.W. Johnson pharmaceutical res. inst., Don Mills ON M3C 1L9, Canada
Source

Transplantation. 1995, Vol 60, Num 4, pp 362-368 ; ref : 35 ref

CODEN
TRPLAU
ISSN
0041-1337
Scientific domain
Graft, transplantation
Publisher
Lippincott, Hagerstown, MD
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Association médicamenteuse Chimiothérapie Ciclosporine Greffon Immunodépresseur Immunomodulateur Maladie greffon hôte Prévention Rejet Système allogénique Traitement Tépoxaline Immunopathologie
Keyword (en)
Drug combination Chemotherapy Graft Immunosuppressive agent Immunomodulator Graft versus host reaction Prevention Rejection Allogeneic system Treatment Immunopathology
Keyword (es)
Asociación medicamentosa Quimioterapia Injerto Inmunodepresor Inmunomodulador Enfermedad injerto huesped Prevención Rechazo Sistema alogénico Tratamiento Inmunopatología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
3654920

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web